546 related articles for article (PubMed ID: 23526226)
21. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
Peng R; Sridhar S; Tyagi G; Phillips JE; Garrido R; Harris P; Burns L; Renteria L; Woods J; Chen L; Allard J; Ravindran P; Bitter H; Liang Z; Hogaboam CM; Kitson C; Budd DC; Fine JS; Bauer CM; Stevenson CS
PLoS One; 2013; 8(4):e59348. PubMed ID: 23565148
[TBL] [Abstract][Full Text] [Related]
22. Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice.
Zhang X; Liu H; Zhou JQ; Krick S; Barnes JW; Thannickal VJ; Sanders YY
Theranostics; 2022; 12(2):530-541. PubMed ID: 34976199
[TBL] [Abstract][Full Text] [Related]
23. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
Okamoto T; Mathai SK; Hennessy CE; Hancock LA; Walts AD; Stefanski AL; Brown KK; Lynch DA; Cosgrove GP; Groshong SD; Cool CD; Schwarz MI; Banda NK; Thurman JM; Yang IV; Holers VM; Schwartz DA
Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L1-L10. PubMed ID: 29565179
[TBL] [Abstract][Full Text] [Related]
24. The Bleomycin Model of Pulmonary Fibrosis.
Liu T; De Los Santos FG; Phan SH
Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
[TBL] [Abstract][Full Text] [Related]
25. Telomeres in Interstitial Lung Disease.
Stock CJW; Renzoni EA
J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33808277
[TBL] [Abstract][Full Text] [Related]
26. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
Zhang X; Liu H; Hock T; Thannickal VJ; Sanders YY
Int J Mol Sci; 2013 Sep; 14(10):19605-17. PubMed ID: 24084714
[TBL] [Abstract][Full Text] [Related]
28. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.
Tang X; Peng R; Phillips JE; Deguzman J; Ren Y; Apparsundaram S; Luo Q; Bauer CM; Fuentes ME; DeMartino JA; Tyagi G; Garrido R; Hogaboam CM; Denton CP; Holmes AM; Kitson C; Stevenson CS; Budd DC
Am J Pathol; 2013 Aug; 183(2):470-9. PubMed ID: 23759512
[TBL] [Abstract][Full Text] [Related]
30. Telomeres in Interstitial Lung Disease: The Short and the Long of It.
Courtwright AM; El-Chemaly S
Ann Am Thorac Soc; 2019 Feb; 16(2):175-181. PubMed ID: 30540921
[TBL] [Abstract][Full Text] [Related]
31. Regulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis.
Gao Y; Zhang J; Liu Y; Zhang S; Wang Y; Liu B; Liu H; Li R; Lv C; Song X
BMC Pulm Med; 2017 Dec; 17(1):163. PubMed ID: 29197377
[TBL] [Abstract][Full Text] [Related]
32. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Diaz de Leon A; Cronkhite JT; Katzenstein AL; Godwin JD; Raghu G; Glazer CS; Rosenblatt RL; Girod CE; Garrity ER; Xing C; Garcia CK
PLoS One; 2010 May; 5(5):e10680. PubMed ID: 20502709
[TBL] [Abstract][Full Text] [Related]
33. Absence of Thy-1 results in TGF-β induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts.
Ramírez G; Hagood JS; Sanders Y; Ramírez R; Becerril C; Segura L; Barrera L; Selman M; Pardo A
Lab Invest; 2011 Aug; 91(8):1206-18. PubMed ID: 21577212
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
[TBL] [Abstract][Full Text] [Related]
35. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
[TBL] [Abstract][Full Text] [Related]
36. Telomere-mediated lung disease.
Alder JK; Armanios M
Physiol Rev; 2022 Oct; 102(4):1703-1720. PubMed ID: 35532056
[TBL] [Abstract][Full Text] [Related]
37. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
[TBL] [Abstract][Full Text] [Related]
38. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
[TBL] [Abstract][Full Text] [Related]
39. The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications.
Arish N; Petukhov D; Wallach-Dayan SB
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248154
[TBL] [Abstract][Full Text] [Related]
40. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
Hannan SJ; Iasella CJ; Sutton RM; Popescu ID; Koshy R; Burke R; Chen X; Zhang Y; Pilewski JM; Hage CA; Sanchez PG; Im A; Farah R; Alder JK; McDyer JF
Am J Transplant; 2023 Oct; 23(10):1590-1602. PubMed ID: 37392813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
